COVID-19 Vaccine in Autoimmune Diseases & Patients on Immunosuppressive Drugs
Notice for Medicare Patients
Medicare is implementing a rule called the “most favored nation rule” (‘MFN’ for short) on January 1st, 2021 which will markedly limit access to your medications. The MFN rule would implement a nationwide mandatory program to automatically lower reimbursement for the top 50 Medicare Part B drugs based on international drug prices. Over one-fifth of the drugs included in the model are routinely used by rheumatology patients.
If you have Medicare, we recommend visiting this website and fill out their letter to demand this rule be stopped.
COVID-19 Information for Patients
Patients with rheumatologic diseases may have many questions and concerns regarding their health and risks of COVID-19. This video will provide information regarding the virus and its effects on patients. It also answers several frequently asked questions. Advanced Rheumatology of Houston is dedicated to caring for patients on every front. Please stay informed and practice healthy habits. Thank you.
More Helpful Resources: